New Amsterdam Partners LLC NY reduced its stake in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 1.7% during the second quarter, Holdings Channel reports. The institutional investor owned 50,937 shares of the medical equipment provider’s stock after selling 881 shares during the period. New Amsterdam Partners LLC NY’s holdings in Varian Medical Systems were worth $5,256,000 as of its most recent filing with the SEC.

Other hedge funds have also recently modified their holdings of the company. First Mercantile Trust Co. increased its stake in shares of Varian Medical Systems by 2.3% in the first quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock valued at $100,000 after buying an additional 25 shares in the last quarter. Parallel Advisors LLC increased its stake in shares of Varian Medical Systems by 16.7% in the first quarter. Parallel Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock valued at $113,000 after buying an additional 176 shares in the last quarter. Heritage Trust Co purchased a new stake in shares of Varian Medical Systems during the first quarter valued at $118,000. Penserra Capital Management LLC increased its stake in shares of Varian Medical Systems by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,610 shares of the medical equipment provider’s stock valued at $146,000 after buying an additional 140 shares in the last quarter. Finally, Pacer Advisors Inc. increased its stake in shares of Varian Medical Systems by 3.1% in the first quarter. Pacer Advisors Inc. now owns 1,815 shares of the medical equipment provider’s stock valued at $165,000 after buying an additional 55 shares in the last quarter. Hedge funds and other institutional investors own 99.27% of the company’s stock.

Varian Medical Systems, Inc. (VAR) opened at 97.74 on Friday. Varian Medical Systems, Inc. has a 1-year low of $75.20 and a 1-year high of $107.08. The firm’s 50-day moving average is $101.70 and its 200 day moving average is $93.39. The firm has a market cap of $8.97 billion, a PE ratio of 32.17 and a beta of 0.61.

Varian Medical Systems (NYSE:VAR) last released its earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.09. Varian Medical Systems had a net margin of 9.50% and a return on equity of 24.70%. The company had revenue of $662.40 million for the quarter, compared to the consensus estimate of $663.86 million. During the same period in the prior year, the company posted $1.00 EPS. The company’s revenue was up 3.0% compared to the same quarter last year. On average, equities analysts forecast that Varian Medical Systems, Inc. will post $3.94 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.dailypolitical.com/2017/08/12/new-amsterdam-partners-llc-ny-sells-881-shares-of-varian-medical-systems-inc-nysevar.html.

Several analysts recently weighed in on the stock. BidaskClub upgraded shares of Varian Medical Systems from a “sell” rating to a “hold” rating in a research report on Saturday. Barrington Research downgraded shares of Varian Medical Systems from an “outperform” rating to a “market perform” rating in a research report on Thursday, April 27th. Robert W. Baird reiterated a “neutral” rating and issued a $99.00 price objective (up from $89.00) on shares of Varian Medical Systems in a research report on Friday, July 14th. Jefferies Group LLC reiterated a “buy” rating on shares of Varian Medical Systems in a research report on Thursday, May 11th. Finally, Royal Bank Of Canada lifted their price objective on shares of Varian Medical Systems from $82.00 to $90.00 and gave the company a “sector perform” rating in a research report on Thursday, April 27th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $96.28.

In other Varian Medical Systems news, EVP Kolleen T. Kennedy sold 26,092 shares of the company’s stock in a transaction dated Tuesday, June 20th. The shares were sold at an average price of $105.00, for a total transaction of $2,739,660.00. Following the transaction, the executive vice president now directly owns 52,692 shares in the company, valued at approximately $5,532,660. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Dow R. Wilson sold 15,059 shares of the company’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $96.48, for a total transaction of $1,452,892.32. Following the transaction, the insider now owns 81,835 shares in the company, valued at $7,895,440.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 158,284 shares of company stock worth $16,022,132. Corporate insiders own 0.91% of the company’s stock.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.